COVID-19 Impact

You may see some delays in posting new content due to COVID-19. If you have any questions, please submit a message to PSNet Support.

PSNet: Patient Safety Network
Journal Article

Medication safety and the administration of intravenous vincristine: international survey of oncology pharmacists.

Gilbar P, Chambers CR, Larizza M. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 2015;21:10-8.

The chemotherapy drug vincristine almost always causes fatal toxicity if it is incorrectly administered intrathecally (via spinal injection) rather than intravenously. This hazard is well publicized, but accidental administration of intrathecal vincristine continues to occur. This survey of oncology pharmacists found that many pharmacies still lack appropriate safeguards to prevent such errors.